Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Return on Capital Employed: 2017-2021

Historic Return on Capital Employed for ENDRA Life Sciences (NDRA) over the last 3 years, with Sep 2021 value amounting to -0.73%.

  • ENDRA Life Sciences' Return on Capital Employed rose 384.00% to -0.73% in Q3 2021 from the same period last year, while for Sep 2021 it was -0.73%, marking a year-over-year increase of 384.00%. This contributed to the annual value of -1.65% for FY2020, which is 47.00% up from last year.
  • According to the latest figures from Q3 2021, ENDRA Life Sciences' Return on Capital Employed is -0.73%, which was down 5.79% from -0.69% recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Return on Capital Employed ranged from a high of 1.26% in Q1 2017 and a low of -6.27% during Q3 2019.
  • Moreover, its 3-year median value for Return on Capital Employed was -2.64% (2020), whereas its average is -2.87%.
  • In the last 5 years, ENDRA Life Sciences' Return on Capital Employed crashed by 197bps in 2018 and then skyrocketed by 423bps in 2021.
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' Return on Capital Employed stood at -0.78% in 2017, then slumped by 197bps to -2.75% in 2018, then tumbled by 52bps to -3.26% in 2019, then spiked by 137bps to -1.89% in 2020, then surged by 384bps to -0.73% in 2021.
  • Its last three reported values are -0.73% in Q3 2021, -0.69% for Q2 2021, and -0.84% during Q1 2021.